Glycoprotein IIB/IIIA inhibitor
Revision as of 20:12, 19 September 2019 by ClaireLewis (talk | contribs) (Created page with "==Background== *By competing with fibrinogen and von Willebrand factor (vWF) for GP IIb/IIIa binding, GP IIb/IIIa antagonists interfere with platelet cross-linking and platele...")
Background
- By competing with fibrinogen and von Willebrand factor (vWF) for GP IIb/IIIa binding, GP IIb/IIIa antagonists interfere with platelet cross-linking and platelet-derived thrombus formation
- Mostly indicated for patients undergoing PCI for ACS
Glycoprotein IIB/IIIA inhibitors=
- Abciximab (ReoPro)
- Eptifibatide (Integrilin)
- Tirofiban (Aggrastat)
